Iran has launched retaliatory attacks on US targets in multiple Middle East countries amid a war triggered by US-Israeli ...

Hollywood has produced countless blockbuster hits over the years, but beyond the widely celebrated titles lies a treasure trove of underrated films that often go unnoticed. These hidden gems may not ...

Google's new default model for generating images, Nano Banana 2 offers faster speeds, better text rendering, and higher resolutions than its predecessor.

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." We've known for a while that excess salt consumption comes with side effects like an increased risk of ...

WEST LAFAYETTE — Purdue football can put three All-Americans – two recently fitted for national championship rings – on the field this season. Barry Odom’s rejuvenation project needs access to and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Live, work, play becomes a ...

The Pittsburgh Steelers have signed two more players to futures contracts after the end to their season. After inking 13 players yesterday, the Steelers signed offensive guard Doug Nester and wide ...

New Gmail features, powered by the Gemini model, are part of Google’s continued push for users to incorporate AI into their daily life and conversations. In Google’s example of what this AI Inbox ...

Gerard Butler returns for more earthshaking action in this crowd-pleasing postapocalyptic thriller. By Robert Daniels When you purchase a ticket for an independently reviewed film through our site, we ...

Dec 16 (Reuters) - U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne Muscular Dystrophy and Metachromatic Leukodystrophy, to the federal newborn ...

Two manufacturing businesses with global sales are investing in Hamilton and adding new jobs. SencorpWhite and Italy-based Salvagnini America, who received tax incentives from the state, will add ...

Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with HER2-positive metastatic breast cancer, ...